Consolidated Statements Of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
OPERATING ACTIVITIES:
Net Income (Loss)	$ 9,452	$ 5,606
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation	2,777	2,940
Deferred income taxes	(3,463)	74
Stock-based compensation expense	2,963	2,722
Change in provision for losses on accounts receivable	12	(149)
Right-of-use asset impairment	14,079	0
(Gain)/loss on disposition of property, plant and equipment	(5,762)	60
Changes in operating assets and liabilities:
Trade receivables	5,771	(567)
Inventories	9,438	25,487
Other current assets	(1,302)	(2,818)
Other assets	(5,638)	(7,623)
Accounts payable - trade	(3,724)	(3,039)
Accrued liabilities	(3,454)	1,561
Other long-term liabilities	204	107
Net cash provided by operating activities	21,353	24,361
INVESTING ACTIVITIES:
Proceeds from sales of investments	1,155
Proceeds from sales of property, plant and equipment	7,538
Capital expenditures	(2,690)	(4,361)
Net cash provided by (used in) investing activities	6,003	(4,361)
FINANCING ACTIVITIES:
Dividends paid	(2,655)	(2,446)
Treasury stock purchases		(1,660)
Proceeds from line of credit	202,344	270,421
Payments on line of credit	(207,262)	(284,510)
Proceeds from issuance of common stock	141	88
Shares withheld for tax payments on vested shares and options exercised	(2,051)	(688)
Net cash (used in) financing activities	(9,483)	(18,795)
Increase in cash and cash equivalents	17,873	1,205
Cash and cash equivalents at beginning of the period	4,761	3,365
Cash and cash equivalents at end of the period	22,634	4,570
SUPPLEMENTAL INFORMATION
Interest paid	107	1,470
Interest received	133
Cash paid for income taxes, net	7,312	3,273
Capital expenditures in accounts payable	$ 28	$ 260